About
Kyinno Bio is a preclinical contract research organization serving biotechnology and pharmaceutical clients. It provides in vitro and in vivo pharmacology, cell line engineering, antibody discovery, and target identification services from Beijing, China, with a business hub in Boston, USA.
Services
In vitro services
Performs cell-based and biochemical in vitro studies for oncology and immunology research, including functional assays and target engagement studies.
Assays & in vitro testing
Cell proliferation assay
Measures compound effects on cell growth and viability using readouts such as CellTiter-Glo, CellCyte, BrdU, and flow cytometry.
Assays & in vitro testing
MegaScreen cell panel screening
Screens compounds across a panel of human cancer cell lines for hit identification, lead optimization, and biomarker development.
Assays & in vitro testing
In vivo services
Offers in vivo pharmacology models for preclinical evaluation, including xenograft, humanized mouse, syngeneic, orthotopic, subcutaneous, and metastasis models.
Assays & in vitro testing
Antibody discovery services
Provides antibody discovery workflows including common light chain, nanobody discovery, AI-based antibody engineering, and off-target screening.
Assays & in vitro testing
Multispecific antibody development platform
Develops bispecific, trispecific, and nanobody-based antibodies using proprietary gene-edited mouse platforms.
Assays & in vitro testing
AI-based antibody development platform
Uses an AI platform to predict antigen-antibody structures and binding affinities, screen antibody sequence libraries, and support affinity maturation.
Assays & in vitro testing
Genetically engineered cell lines
Develops and supplies engineered cell lines for disease, therapy, and biological process studies.
Cell line development
Drug combination services
Evaluates in vitro and in vivo combination studies for drug development programs.
Assays & in vitro testing
- Turnaround
- 2 - 14 day Standard Assay Window
- What to send
- Custom assays · Custom antibodies · Cell lines · In vivo model requests
Capabilities
- Assays and studies
- Antibodies · In vivo · Rodent models · Bispecifics · ELISA · Flow cytometry · Cell proliferation · Cell viability · Cell panel screening · Immuno-oncology assay · ADCC · ADCP
4 more
FACS binding assay · Internalization assay · 3D organoid culture · Immune cell assay - Scale and capacity
- 3000+ engineered cell lines · 5000-antibody specificity screening MPSA-AB5000 panel · Over 700 sequenced and certified human cancer cell lines · 100+ validated assay platforms · 6000+ cell lines available · 5-floor, 5000m² laboratory · 130 professionals · Over 1,000 partners
- Therapeutic areas
- Oncology · Immunology · Cancer drug discovery · Cancer drug development
Instruments and platforms
- CellTiter-Glo
- CellCyte
- BrdU
- Flow cytometry
- Digital PCR
- Mass spectrometry
Modalities and species
- Modalities
- Small molecule · Antibody · Bispecific · ADC · Cell therapy
- Species and models
- Human cancer cell lines · PBMC humanized mouse · Syngeneic mouse · Orthotopic model · Subcutaneous model · Metastasis model · Ba/F3 xenograft model · Gene-editing xenograft model · Luciferase tumor model
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
As listed: GLP-Aligned QC; GLP-Aligned Protocols
Company
- Type
- CRO
- Founded
- 2017
- Team
- 130 professionals
- Quality
- GLP-Aligned QC · GLP-Aligned Protocols
Locations
- Address
- 3 Gill Street, suite 100, Woburn, MA, 01801
- Sites
- Beijing, China · Woburn, MA, USA
- Serves
- global
Similar labs
Work here? Claim this listing